[easl]

1) Telaprevir Achieves 75% Rate of Sustained HCV Response: Study
[Ссылки доступны только зарегистрированным пользователям ]

2)Hepatitis C Coinfection Increases Adverse Reactions to HAART
[Ссылки доступны только зарегистрированным пользователям ]

"HCV viremia seems to exacerbate adverse reactions, such as rash and hepatotoxicity, to nevirapine-based HAART," the authors conclude. "We suggest nevirapine not be used as part of a HAART regimen when HCV RNA replication exists."

3) Diagnosis and Management of Acute Liver Failure
[Ссылки доступны только зарегистрированным пользователям ]